[go: up one dir, main page]

DK0698111T3 - Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer - Google Patents

Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer

Info

Publication number
DK0698111T3
DK0698111T3 DK94917312T DK94917312T DK0698111T3 DK 0698111 T3 DK0698111 T3 DK 0698111T3 DK 94917312 T DK94917312 T DK 94917312T DK 94917312 T DK94917312 T DK 94917312T DK 0698111 T3 DK0698111 T3 DK 0698111T3
Authority
DK
Denmark
Prior art keywords
hmg
coa reductase
reductase inhibitors
synthesis
image
Prior art date
Application number
DK94917312T
Other languages
English (en)
Inventor
Giorgio Carta
Michael J Conder
John Lloyd Gainer
Robert W Stieberg
Victor A Vinci
Timothy Wallace Weber
Original Assignee
Merck & Co Inc
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Univ Virginia filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0698111T3 publication Critical patent/DK0698111T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/921Candida

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK94917312T 1993-05-11 1994-05-06 Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer DK0698111T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/060,847 US5420024A (en) 1993-05-11 1993-05-11 Process for synthesis of acylated HMG-CoA reductase inhibitors from a lactone diol precursor using Candida cylindracea
PCT/US1994/005019 WO1994026920A1 (en) 1993-05-11 1994-05-06 PROCESS FOR SYNTHESIS OF HMG-CoA REDUCTASE INHIBITORS

Publications (1)

Publication Number Publication Date
DK0698111T3 true DK0698111T3 (da) 2003-03-31

Family

ID=22032112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917312T DK0698111T3 (da) 1993-05-11 1994-05-06 Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer

Country Status (10)

Country Link
US (1) US5420024A (da)
EP (1) EP0698111B1 (da)
JP (1) JPH08510128A (da)
AT (1) ATE232910T1 (da)
AU (1) AU673268B2 (da)
CA (1) CA2161788C (da)
DE (1) DE69432144T2 (da)
DK (1) DK0698111T3 (da)
ES (1) ES2190441T3 (da)
WO (1) WO1994026920A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
US7141602B2 (en) * 1998-09-18 2006-11-28 Lek Pharmaceuticals D.D. Process for obtaining HMG-CoA reductase inhibitors of high purity
CA2388182A1 (en) 1999-10-27 2001-05-03 Merck & Co., Inc. Lactonization process
US7700329B2 (en) * 2003-10-21 2010-04-20 Brian Morgan Methods for making simvastatin and intermediates
US20110059493A1 (en) * 2007-08-27 2011-03-10 Brian Morgan Methods for Making Simvastatin and Intermediates
US8383382B2 (en) 2009-09-30 2013-02-26 Codexis, Inc. Variant LovD polypeptides and their uses
EP2486129B1 (en) 2009-10-08 2016-04-13 The Regents of The University of California LovD MUTANTS EXHIBITING IMPROVED PROPERTIES TOWARDS SIMVASTATIN SYNTHESIS
KR102051508B1 (ko) * 2018-07-23 2019-12-03 중앙대학교 산학협력단 프로피오닐 에스테르 유도체를 유효성분으로 함유하는 x-연관 부신백질이영양증 예방 또는 치료용 약학조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60176595A (ja) * 1984-02-21 1985-09-10 Akira Endo 生理活性物質ml−236a及びモナコリンjの製造法
US5223415A (en) * 1990-10-15 1993-06-29 Merck & Co., Inc. Biosynthetic production of 7-[1',2',6',7',8',8a'(R)-hexahydro-2'(S),6'(R)-dimethyl-8'(S)-hydroxy-1'(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid)
GB2255974A (en) * 1991-05-24 1992-11-25 Merck & Co Inc Enzymatic deacylation of simvastatin

Also Published As

Publication number Publication date
JPH08510128A (ja) 1996-10-29
EP0698111A4 (en) 1998-08-26
DE69432144D1 (de) 2003-03-27
ES2190441T3 (es) 2003-08-01
US5420024A (en) 1995-05-30
CA2161788C (en) 2001-10-16
EP0698111B1 (en) 2003-02-19
ATE232910T1 (de) 2003-03-15
EP0698111A1 (en) 1996-02-28
CA2161788A1 (en) 1994-11-24
AU673268B2 (en) 1996-10-31
AU6907294A (en) 1994-12-12
DE69432144T2 (de) 2003-11-13
WO1994026920A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
ES2073529T3 (es) Inhibidor de fosfolipasa a2, microorganismos que producen este inhibidor y procedimiento para su produccion.
DE04010770T1 (de) Verfahren zur Rückgewinnung von Statinverbindungen aus einer Fermentationsbrühe
DK0698111T3 (da) Fremgangsmåde til syntese af HMG-CoA-reduktaseinhibitorer
ES2061451T3 (es) Derivados de trans-6-(2-(n-heteroaril-3,5-disubstituido)pirazol-4-il)-etil)- o etenil)tetrahidro-4-hidroxipiran-2-ona, un proceso para su preparacion y uso de los mismos.
ATE296357T1 (de) Verfahren zur herstellung von hochreinen hmg-coa reductase inhibitoren
Lakshmipathi et al. Efficient conjugate addition of hydrogen azide to enoates
Kawasaki et al. Asymmetric synthesis of 2-substituted chroman-4-ones using lipase-catalyzed kinetic resolutions
Liang et al. Chemoenzymatic synthesis of isogalactofagomine
DK0649907T3 (da) Enzymatisk hydroxyleringsproces til fremstilling af HMG-CoA-reduktaseinhibitorer og mellemprodukter derfor
DK0734392T3 (da) Omdannelse af bisnoralkohol til bisnoraldehyd
EP0605033B1 (en) Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
CA1245226A (en) METHOD FOR THE PREPARATION OF HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATE COMPOUNDS
AU3284699A (en) Process for the preparation of simvastatin and derivatives thereof
EP0927755A3 (en) Haloaccloacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme
NO306297B1 (no) FremgangsmÕte for fremstilling av HIV-proteaseinhibitorer
MURATA et al. Asymmetric synthesis of a chiral norbornene derivative by lipase-catalyzed transesterification of cis-endo-5-norbornene-2, 3-dimethanol and its application to the synthesis of an optically active TXA2 antagonist
EP1288213A4 (en) METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE 2- [6- (HYDROXYMETHYL) -1,3-DIOXAN-4-YL] ACETIC ACID DERIVATIVES (12/19/01)
ES2176463T3 (es) Procedimiento para producir derivados de 1-halo-3-amino-4fenil-2-butanol opticamente activos.
Caro et al. Synthesis of optically active β-benzyl-γ-butyrolactone through lipase-catalyzed kinetic resolution
Kalamkar et al. Total synthesis of natural cis-3-hydroxy-L-proline from D-glucose
Rychnovsky et al. Enantioselective reduction of esters: synthesis of optically active α-acetoxy ethers
Petschen et al. Enzyme-catalyzed synthesis and absolute configuration of (1S, 2R, 5S)-and (1R, 2S, 5R)-2-(1-hydroxyethyl)-1-(methoxymethyloxyethyl) cyclobutane-1-carbonitrile, key intermediates for the preparation of chiral cyclobutane-containing pheromones
DK0955297T3 (da) Forbedret fremgangsmåde til lactonisering i fremstillingen af statiner
DK0624568T3 (da) Forbedret fremgangsmåde til fremstilling af L-(-)-carnitin ud fra et affaldsprodukt med modsat konfiguration
Shimada et al. Efficient stereocontrol of a quaternary chiral center in the cyclohexene systems. Potential chiral synthons for vitamin D and related compounds by enzymatic approach